Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 52 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 39 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows.
BofA Initiates Arcellx With Buy On Its Novel Therapy Approach
Arcellx (NASDAQ: ACLX) is advancing into pivotal testing (by year-end 2022) of its B-cell maturation antigen (BCMA) directed combination antiretroviral therapy (CART), known as ddBCMA, for relapsed refractory multiple myeloma, according to BofA Securities.
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the holiday-shortened week before making a comeback.
Hanesbrands And 2 Other Stocks Bought By Insiders
US stock futures traded lower this morning after recording sharp losses in the previous session. Investors, meanwhile, focused on some notable insider trades.
Insiders Buy Over $43M Of 4 Stocks
US stock futures traded mixed this morning ahead of the inflation data due today. Investors, meanwhile, focused on some notable insider trades
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.